부산대학교 도서관

Trebeschi, S. ; Drago, S.G. ; Birkbak, N.J. ; Kurilova, I. ; Cǎlin, A.M. ; Delli Pizzi, A. ; Lalezari, F. ; Lambregts, D.M.J. ; Rohaan, M.W. ; Parmar, C. ; Rozeman, E.A. ; Hartemink, K.J. ; Swanton, C. ; Haanen, J B A G ; Blank, C.U. ; Smit, E.F. ; Beets-Tan, R.G.H. ; Aerts, H.J.W.L

In Annals of Oncology June 2019 30(6):998-1004

Egeler MD; Division of Psychosocial Research and Epidemiology, The Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands. m.egeler@nki.nl.; Boomstra E; Division of Psychosocial Research and Epidemiology, The Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.; Rohaan MW; Division of Medical Oncology, The Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.; Van den Heuvel NMJ; Division of Psychosocial Research and Epidemiology, The Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.; Fraterman I; Division of Psychosocial Research and Epidemiology, The Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.; Delfos M; Division of Medical Oncology, The Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.; van de Poll-Franse LV; Division of Psychosocial Research and Epidemiology, The Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.; Department of Research & Development, Netherlands Comprehensive Cancer Organisation (IKNL), Utrecht, The Netherlands.; Department of Medical and Clinical Psychology, Center of Research on Psychology in Somatic Diseases (CoRPS), Tilburg University, Tilburg, The Netherlands.; Borch TH; National Center for Cancer Immune Therapy, Department of Oncology, Copenhagen University Hospital, Herlev, Denmark.; Svane IM; National Center for Cancer Immune Therapy, Department of Oncology, Copenhagen University Hospital, Herlev, Denmark.; Haanen JBAG; Division of Medical Oncology, The Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.; Division of Molecular Oncology and Immunology, Netherlands Cancer Institute, Amsterdam, The Netherlands.; Department of Clinical Oncology, Leiden University Medical Center, Leiden, The Netherlands.; Retèl VP; Division of Psychosocial Research and Epidemiology, The Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.; Erasmus School of Health Policy and Management, Erasmus University Rotterdam, Rotterdam, The Netherlands.; Boekhout AH; Division of Psychosocial Research and Epidemiology, The Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.

Publisher: Springer Science + Business Media Country of Publication: United States NLM ID: 101307557 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1932-2267 (Electronic) Linking ISSN: 19322259 NLM ISO Abbreviation: J Cancer Surviv Subsets: MEDLINE

Bloem M; Scientific Bureau, Dutch Institute for Clinical Auditing, Rijnsburgerweg 10, Leiden 2333AA, the Netherlands; Department of Biomedical Data Sciences, Leiden University Medical Centre, Einthovenweg 20, Leiden 2333ZC, the Netherlands; Department of Surgical Oncology, Netherlands Cancer Institute, Plesmanlaan 121, Amsterdam 1066CX, the Netherlands. Electronic address: m.bloem@lumc.nl.; van den Eertwegh AJM; Department of Medical Oncology, Amsterdam UMC, VU University Medical Center, Cancer Center Amsterdam, De Boelelaan 1118, Amsterdam 1081HZ, the Netherlands.; Haanen JBAG; Department of Medical Oncology & Immunology, Netherlands Cancer Institute, Plesmanlaan 121, Amsterdam 1066CX, the Netherlands; Department of Medical Oncology, Leiden University Medical Centre, Albinusdreef 2, Leiden 2333ZA, the Netherlands.; Aarts MJB; Department of Medical Oncology, GROW School for Oncology and Reproduction, Maastricht University Medical Centre+, P. Debyelaan 25, Maastricht 6229 HX, the Netherlands.; van den Berkmortel FWPJ; Department of Medical Oncology, Zuyderland Medical Centre Sittard, Dr. H. van der Hoffplein 1, Sittard-Geleen 6162BG, the Netherlands.; Blank CU; Department of Medical Oncology & Immunology, Netherlands Cancer Institute, Plesmanlaan 121, Amsterdam 1066CX, the Netherlands.; Blokx WAM; Department of Pathology, University Medical Center Utrecht, Heidelberglaan 100, Utrecht 3584CX, the Netherlands.; Boers-Sonderen MJ; Department of Medical Oncology, Radboud University Medical Centre, Geert Grooteplein Zuid 10, Nijmegen 6525GA, the Netherlands.; Boreel CDM; Scientific Bureau, Dutch Institute for Clinical Auditing, Rijnsburgerweg 10, Leiden 2333AA, the Netherlands; Department of Medical Oncology, University Medical Center Utrecht, Utrecht University, Heidelberglaan 100, Utrecht 3584CX, the Netherlands.; de Groot JWB; Isala Oncology Center, Isala, Dokter van Heesweg 2, Zwolle 8025AB, the Netherlands.; Hospers GAP; Department of Medical Oncology, University Medical Centre Groningen, University of Groningen, Hanzeplein 1, Groningen 9713GZ, the Netherlands.; Kapiteijn E; Department of Medical Oncology, Leiden University Medical Centre, Albinusdreef 2, Leiden 2333ZA, the Netherlands.; Piersma D; Department of Internal Medicine, Medisch Spectrum Twente, Koningsplein 1, Enschede 7512KZ, the Netherlands.; Rikhof B; Department of Internal Medicine, Medical Centre Leeuwarden, Henri Dunantweg 2, Leeuwarden 8934AD, the Netherlands.; Simkens LHJ; Department of Internal Medicine, Maxima Medical Centre, De Run 4600, Eindhoven 5504DB, the Netherlands.; Stevense-den Boer AM; Department of Internal Medicine, Amphia Hospital, Molengracht 21, Breda 4818CK, the Netherlands.; van der Veldt AAM; Department of Medical Oncology and Radiology & Nuclear Medicine, Erasmus Medical Centre, 's-Gravendijkwal 230, Rotterdam 3015CE, the Netherlands.; Wouters MWJM; Scientific Bureau, Dutch Institute for Clinical Auditing, Rijnsburgerweg 10, Leiden 2333AA, the Netherlands; Department of Biomedical Data Sciences, Leiden University Medical Centre, Einthovenweg 20, Leiden 2333ZC, the Netherlands; Department of Surgical Oncology, Netherlands Cancer Institute, Plesmanlaan 121, Amsterdam 1066CX, the Netherlands.; Suijkerbuijk KPM; Department of Medical Oncology, University Medical Center Utrecht, Utrecht University, Heidelberglaan 100, Utrecht 3584CX, the Netherlands.

Publisher: Elsevier Science Ltd Country of Publication: England NLM ID: 9005373 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0852 (Electronic) Linking ISSN: 09598049 NLM ISO Abbreviation: Eur J Cancer Subsets: MEDLINE

Ten Ham RMT; Division of Psychosocial Research and Epidemiology, Netherlands Cancer Institute, Amsterdam, The Netherlands; Department of Epidemiology & Health Economics, Julius Center for Health Sciences and Primary Care, UMC Utrecht, Utrecht, The Netherlands.; Rohaan MW; Division of Medical Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands.; Egeler M; Division of Psychosocial Research and Epidemiology, Netherlands Cancer Institute, Amsterdam, The Netherlands.; Menezes R; Division of Psychosocial Research and Epidemiology, Netherlands Cancer Institute, Amsterdam, The Netherlands.; Holz Borch T; Department of Oncology, National Center for Cancer Immune Therapy, Copenhagen University Hospital, Herlev, Denmark.; Kessels R; Division of Biometrics, Netherlands Cancer Institute, Amsterdam, The Netherlands.; Jedema I; Biotherapeutics Unit, Netherlands Cancer Institute, Amsterdam, The Netherlands.; Nuijen B; Division of Pharmacy and Pharmacology, Netherlands Cancer Institute, Amsterdam, The Netherlands.; Nijenhuis CM; Division of Pharmacy and Pharmacology, Netherlands Cancer Institute, Amsterdam, The Netherlands.; van de Poll-Franse LV; Division of Psychosocial Research and Epidemiology, Netherlands Cancer Institute, Amsterdam, The Netherlands.; Geukes Foppen MH; Division of Medical Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands.; Lindenberg M; Division of Psychosocial Research and Epidemiology, Netherlands Cancer Institute, Amsterdam, The Netherlands.; Mansfield Noringriis I; Department of Oncology, National Center for Cancer Immune Therapy, Copenhagen University Hospital, Herlev, Denmark.; Monberg TJ; Department of Oncology, National Center for Cancer Immune Therapy, Copenhagen University Hospital, Herlev, Denmark.; Donia M; Department of Oncology, National Center for Cancer Immune Therapy, Copenhagen University Hospital, Herlev, Denmark.; van Harten W; Division of Psychosocial Research and Epidemiology, Netherlands Cancer Institute, Amsterdam, The Netherlands.; Svane IM; Department of Oncology, National Center for Cancer Immune Therapy, Copenhagen University Hospital, Herlev, Denmark.; Haanen JBAG; Division of Medical Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands; Division of Molecular Oncology and Immunology, Netherlands Cancer Institute, Amsterdam, The Netherlands; Department of Medical Oncology, Leiden University Medical Center, Leiden, The Netherlands.; Retèl VP; Division of Psychosocial Research and Epidemiology, Netherlands Cancer Institute, Amsterdam, The Netherlands; Erasmus School of Health Policy & Management, Erasmus University Rotterdam, Rotterdam, The Netherlands. Electronic address: v.retel@nki.nl.

Publisher: Elsevier Country of Publication: England NLM ID: 9007735 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1569-8041 (Electronic) Linking ISSN: 09237534 NLM ISO Abbreviation: Ann Oncol Subsets: MEDLINE

Larkin, J.M.G. ; Chiarion-Sileni, V. ; Gonzalez, R. ; Grob, J.J. ; Rutkowski, P. ; Lao, C. ; Cowey, C.L. ; Schadendorf, D. ; Wagstaff, J. ; Dummer, R. ; Ferrucci, P.F. ; Smylie, M. ; Hogg, D. ; Hill, A. ; Marquez-Rodas, I. ; Haanen, J B A G ; Rizzo, J. ; Balogh, A. ; Hodi, F.S. ; Wolchok, J.

In Annals of Oncology October 2019 30 Supplement 5:v904-v905

Rozeman, E.A. ; Moritz, R. ; Wilgenhof, S. ; van Thienen, J.V. ; Haanen, J B A G ; van den Heuvel, M. ; Blank, C.U. ; Van Rossum, H.

In Annals of Oncology October 2019 30 Supplement 5:v553-v553

van Zeijl, M.C.T. ; Wouters, M W J M ; van den Eertwegh, A.J.M. ; de Wreede, L.C. ; Aarts, M.J.B. ; van Akkooi, A.C.J. ; Van den Berkmortel, F W P J ; de Groot, J.W. ; Boers-Sonderen, M.J. ; van der Hoeven, J.J.M. ; Hospers, G.A.P. ; Kapiteijn, E. ; Piersma, D. ; van Rijn, R.S. ; Suijkerbuijk, K.P.M. ; Ten Tije, A.J. ; Van der Veldt, A.A.M. ; Vreugdenhil, G. ; Haanen, J B A G

In Annals of Oncology October 2019 30 Supplement 5:v552-v552

Blank, C.U. ; Versluis, J.M. ; Reijers, I.L.M. ; Sikorska, K. ; van Houdt, W.J. ; van Thienen, J.V. ; Adriaansz, S. ; Mallo, H.A. ; van Tinteren, H. ; van de Wiel, B.A. ; Grijpink-Ongering, L.G. ; Bruining, A. ; Haanen, J B A G ; van Akkooi, A.C.J. ; Schumacher, T.N. ; Rozeman, E.A.

In Annals of Oncology October 2019 30 Supplement 5:v535-v535

Nguyen-Kim, T.D.L. ; Trebeschi, S. ; Pouw, J.E.E. ; Milanese, G. ; Topff, L. ; Bodalal, Z. ; Mangana, J. ; Frauenfelder, T. ; Haanen, J B A G ; Blank, C.U. ; Aerts, H J W L ; Beets-Tan, R. ; Dummer, R.

In Annals of Oncology October 2019 30 Supplement 5:v529-v529

Kostine, M. ; Finckh, A. ; Bingham, C.O. ; Visser, K. ; Leipe, J. ; Schulze-Koops, H. ; Choy, E. ; Benesova, K. ; Radstake, T. ; Cope, A. ; Lambotte, O. ; Gottenberg, J.-E. ; Allenbach, Y. ; Jamal, S. ; Marabelle, A. ; Larkin, J.M.G. ; Haanen, J B A G ; Calabrese, L. ; Mariette, X. ; Schaeverbeke, T.

In Annals of Oncology October 2019 30 Supplement 5:v528-v528

Rohaan, M.W. ; Gomez-Eerland, R. ; Foppen, M H Geukes ; van Zon, M. ; de Boer, R. ; Bakker, N.A.M. ; Pronk, L.M. ; Sari, A. ; Mallo, H.A. ; van de Wiel, B.A. ; Lalezari, F. ; Beijnen, J.H. ; Nuijen, B. ; van Tinteren, H. ; van Thienen, J.V. ; Blank, C.U. ; Wilgenhof, S. ; Schumacher, T.N. ; van den Berg, J.H. ; Haanen, J B A G

In Annals of Oncology October 2019 30 Supplement 5:v481-v482

Albiges, L. ; Rini, B.I. ; Haanen, J B A G ; Motzer, R.J. ; Kollmannsberger, C.K. ; Negrier, S. ; Nole, F. ; Bedke, J. ; Bilen, M.A. ; Nathan, P. ; Tomita, Y. ; Huang, B. ; Ching, K.A. ; Chudnovsky, A. ; Robbins, P.B. ; di Pietro, A. ; Thomaidou, D. ; Choueiri, T.K.

In Annals of Oncology October 2019 30 Supplement 5:v359-v360

Martín-Lluesma S; Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain; Department of Basic Medical Sciences, Faculty of Medicine, San Pablo-CEU University, CEU Universities, Madrid, Spain.; Dafni U; Faculty of Nursing, National and Kapodistrian University of Athens, Athens, Greece; Department of Oncology, CHUV, University of Lausanne, Lausanne, Switzerland. Electronic address: udafni@nurs.uoa.gr.; Vervita K; Scientific Research Consulting Hellas, Statistics Center, Athens, Greece.; Karlis D; Department of Statistics, Athens University of Economics and Business, Athens, Greece.; Dimopoulou G; Scientific Research Consulting Hellas, Statistics Center, Athens, Greece.; Tsourti Z; Scientific Research Consulting Hellas, Statistics Center, Athens, Greece.; Villacampa G; Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.; Galvao V; Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.; Lostes J; Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain; Department of Medical Oncology, Vall d'Hebron University Hospital, Barcelona, Spain.; Muñoz-Couselo E; Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain; Department of Medical Oncology, Vall d'Hebron University Hospital, Barcelona, Spain.; Rotxés M; Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.; Villalobos X; Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.; Muñoz S; Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.; Haanen JBAG; Division of Medical Oncology, Netherlands Cancer Institute (NKI), Amsterdam, The Netherlands; Department of Medical Oncology, Leiden University Medical Oncology, Leiden, The Netherlands; Melanoma Clinic, CHUV, Lausanne, Switzerland.; Svane IM; Department of Oncology, National Center for Cancer Immune Therapy (CCIT-DK), Copenhagen University Hospital, Herlev, Denmark.; Piulats JM; Catalan Institute of Oncology (ICO), Barcelona, Spain.; Martin-Liberal J; Catalan Institute of Oncology (ICO), Barcelona, Spain.; Gros A; Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.; Coukos G; Department of Oncology, Lausanne University Hospital and University of Lausanne Ludwig Institute for Cancer Research Lausanne Branch, Lausanne, Switzerland.; Garralda E; Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain; Department of Medical Oncology, Vall d'Hebron University Hospital, Barcelona, Spain.

Publisher: Elsevier Country of Publication: England NLM ID: 9007735 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1569-8041 (Electronic) Linking ISSN: 09237534 NLM ISO Abbreviation: Ann Oncol Subsets: MEDLINE

Lankheet, N A G; Kloth, J S L; Gadellaa-van Hooijdonk, C G M; Cirkel, G A; Mathijssen, R H J; Lolkema, M P J K; Schellens, J H M; Voest, E E; Sleijfer, S; de Jonge, M J A; Haanen, J B A G; Beijnen, J H; Huitema, A D R; Steeghs, N

British Journal of Cancer. 5/13/2014, Vol. 110 Issue 10, p2441-2449. 9p.

Moulin, V; Morgan, M E; Eleveld-Trancikova, D; Haanen, J B A G; Wielders, E; Looman, M W G; Janssen, R A J; Figdor, C G; Jansen, B J H; Adema, G J

Cancer Gene Therapy. May2012, Vol. 19 Issue 5, p303-311. 9p. 1 Diagram, 2 Charts, 5 Graphs.

van der Veldt, A A M; Boven, E; Helgason, H H; van Wouwe, M; Berkhof, J; de Gast, G; Mallo, H; Tillier, C N; van den Eertwegh, A J M; Haanen, J B A G

British Journal of Cancer. 7/22/2008, Vol. 99 Issue 2, p259-265. 7p. 5 Charts, 2 Graphs.

Borgers JSW; Department of Medical Oncology, Antoni van Leeuwenhoek-The Netherlands Cancer Institute, Amsterdam, The Netherlands.; Burgers FH; Department of Medical Oncology, Antoni van Leeuwenhoek-The Netherlands Cancer Institute, Amsterdam, The Netherlands.; Schina A; National Center for Cancer Immune Therapy, Department of Oncology, Copenhagen University Hospital, Herlev, Denmark.; Van Not OJ; Dutch Institute for Clinical Auditing, Leiden, The Netherlands.; Department of Medical Oncology, University Medical Center Utrecht, Utrecht, The Netherlands.; van den Eertwegh AJM; Department of Medical Oncology, Amsterdam UMC, VU University Medical Center, Cancer Center Amsterdam, Amsterdam, The Netherlands.; Blank CU; Department of Medical Oncology, Antoni van Leeuwenhoek-The Netherlands Cancer Institute, Amsterdam, The Netherlands.; Aarts MJB; Department of Medical Oncology, GROW School for Oncology and Developmental Biology, Maastricht University Medical Centre+, Maastricht, The Netherlands.; van den Berkmortel FWPJ; Department of Medical Oncology, Zuyderland Medical Centre, Sittard, The Netherlands.; de Groot JWB; Isala Oncology Center, Zwolle, The Netherlands.; Hospers GAP; Department of Medical Oncology, University Medical Centre Groningen, University of Groningen, Groningen, The Netherlands.; Kapiteijn E; Department of Medical Oncology, Leiden University Medical Centre, Leiden, The Netherlands.; Piersma D; Department of Internal Medicine, Medisch Spectrum Twente, Enschede, The Netherlands.; van Rijn RS; Department of Internal Medicine, Medical Centre Leeuwarden, Leeuwarden, The Netherlands.; Boer AMS; Department of Internal Medicine, Amphia Hospital, Breda, The Netherlands.; van der Veldt AAM; Department of Medical Oncology and Radiology & Nuclear Medicine, Erasmus Medical Centre, Rotterdam, The Netherlands.; Vreugdenhil G; Department of Internal Medicine, Maxima Medical Center, Veldhoven, The Netherlands.; Boers-Sonderen MJ; Department of Medical Oncology, Radboud University Medical Centre, Nijmegen, The Netherlands.; Wouters MWJM; Dutch Institute for Clinical Auditing, Leiden, The Netherlands.; Department of Biomedical Data Sciences, Leiden University Medical Centre, Leiden, The Netherlands.; Department of Surgical Oncology, Antoni van Leeuwenhoek-The Netherlands Cancer Institute, Amsterdam, The Netherlands.; Suijkerbuijk KPM; Department of Medical Oncology, University Medical Center Utrecht, Utrecht, The Netherlands.; van Thienen JV; Department of Medical Oncology, Antoni van Leeuwenhoek-The Netherlands Cancer Institute, Amsterdam, The Netherlands.; Haanen JBAG; Department of Medical Oncology, Antoni van Leeuwenhoek-The Netherlands Cancer Institute, Amsterdam, The Netherlands.

Publisher: Blackwell Munksgaard Country of Publication: England NLM ID: 101318927 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1755-148X (Electronic) Linking ISSN: 17551471 NLM ISO Abbreviation: Pigment Cell Melanoma Res Subsets: MEDLINE

Bloem M; Scientific Bureau, Dutch Institute for Clinical Auditing, Rijnsburgerweg 10, Leiden 2333AA, the Netherlands; Department of Biomedical Data Sciences, Leiden University Medical Centre, Einthovenweg 20, Leiden 2333ZC, the Netherlands; Department of Surgical Oncology, Netherlands Cancer Institute, Plesmanlaan 121, Amsterdam 1066CX, the Netherlands. Electronic address: m.bloem@lumc.nl.; Suijkerbuijk KPM; Department of Medical Oncology, University Medical Center Utrecht, Utrecht University, Heidelberglaan 100, Utrecht 3584CX, the Netherlands.; Aarts MJB; Department of Medical Oncology, GROW School for Oncology and Reproduction, Maastricht University Medical Centre+, P. Debyelaan 25, Maastricht 6229 HX, the Netherlands.; van den Berkmortel FWPJ; Department of Medical Oncology, Zuyderland Medical Centre Sittard, Dr. H. van der Hoffplein 1, Sittard-Geleen 6162BG, the Netherlands.; Blank CU; Department of Medical Oncology & Immunology, Netherlands Cancer Institute, Plesmanlaan 121, Amsterdam 1066CX, the Netherlands.; Blokx WAM; Department of Pathology, University Medical Center Utrecht, Heidelberglaan 100, Utrecht 3584CX, the Netherlands.; Boers-Sonderen MJ; Department of Medical Oncology, Radboud University Medical Centre, Geert Grooteplein Zuid 10, Nijmegen 6525GA, the Netherlands.; Boreel CDM; Scientific Bureau, Dutch Institute for Clinical Auditing, Rijnsburgerweg 10, Leiden 2333AA, the Netherlands; Department of Medical Oncology, University Medical Center Utrecht, Utrecht University, Heidelberglaan 100, Utrecht 3584CX, the Netherlands.; de Groot JWB; Isala Oncology Center, Isala, Dokter van Heesweg 2, Zwolle 8025AB, the Netherlands.; Haanen JBAG; Department of Medical Oncology & Immunology, Netherlands Cancer Institute, Plesmanlaan 121, Amsterdam 1066CX, the Netherlands.; Hospers GAP; Department of Medical Oncology, University Medical Centre Groningen, University of Groningen, Hanzeplein 1, Groningen 9713GZ, the Netherlands.; Kapiteijn E; Department of Medical Oncology, Leiden University Medical Centre, Albinusdreef 2, Leiden 2333ZA, the Netherlands.; van Not OJ; Scientific Bureau, Dutch Institute for Clinical Auditing, Rijnsburgerweg 10, Leiden 2333AA, the Netherlands; Department of Medical Oncology, University Medical Center Utrecht, Utrecht University, Heidelberglaan 100, Utrecht 3584CX, the Netherlands.; Piersma D; Department of Internal Medicine, Medisch Spectrum Twente, Koningsplein 1, Enschede 7512KZ, the Netherlands.; Rikhof B; Department of Internal Medicine, Medical Centre Leeuwarden, Henri Dunantweg 2, Leeuwarden 8934AD, the Netherlands.; Stevense-den Boer AM; Department of Internal Medicine, Amphia Hospital, Molengracht 21, Breda 4818CK, the Netherlands.; van der Veldt AAM; Department of Medical Oncology and Radiology & Nuclear Medicine, Erasmus Medical Centre, Gravendijkwal 230, Rotterdam 3015CE, the Netherlands.; Vreugdenhil G; Department of Internal Medicine, Maxima Medical Centre, De Run 4600, Eindhoven 5504DB, the Netherlands.; Wouters MWJM; Scientific Bureau, Dutch Institute for Clinical Auditing, Rijnsburgerweg 10, Leiden 2333AA, the Netherlands; Department of Biomedical Data Sciences, Leiden University Medical Centre, Einthovenweg 20, Leiden 2333ZC, the Netherlands; Department of Surgical Oncology, Netherlands Cancer Institute, Plesmanlaan 121, Amsterdam 1066CX, the Netherlands.; van den Eertwegh AJM; Department of Medical Oncology, Amsterdam UMC, VU University Medical Center, Cancer Center Amsterdam, De Boelelaan 1118, Amsterdam 1081HZ, the Netherlands.

Publisher: Elsevier Science Ltd Country of Publication: England NLM ID: 9005373 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0852 (Electronic) Linking ISSN: 09598049 NLM ISO Abbreviation: Eur J Cancer Subsets: MEDLINE

Ketelaars SLC; Division of Molecular Oncology & Immunology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.; van Buuren MM; Division of Molecular Oncology & Immunology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.; Gangaev A; Division of Molecular Oncology & Immunology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.; van Rooij N; Division of Molecular Oncology & Immunology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.; Patiwael S; Division of Molecular Oncology & Immunology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.; Hoefakker K; Division of Molecular Oncology & Immunology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.; Fanchi LF; Division of Molecular Oncology & Immunology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.; Oncode Institute, Utrecht, The Netherlands.; Baas P; Department of Thoracic Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.; van der Heijden M; Department of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.; Kok M; Division of Molecular Oncology & Immunology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.; Department of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.; Schumacher TN; Division of Molecular Oncology & Immunology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.; Oncode Institute, Utrecht, The Netherlands.; Kvistborg P; Division of Molecular Oncology & Immunology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.; Haanen JBAG; Division of Molecular Oncology & Immunology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.; Department of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.; Department of Medical Oncology, Leiden University Medical Center, Leiden, The Netherlands.

Publisher: Elsevier Ltd Country of Publication: England NLM ID: 9918281581106676 Publication Model: eCollection Cited Medium: Internet ISSN: 2590-0188 (Electronic) Linking ISSN: 25900188 NLM ISO Abbreviation: Immunooncol Technol Subsets: PubMed not MEDLINE

Hoeijmakers LL; Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, the Netherlands.; Rozeman EA; Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, the Netherlands.; Lopez-Yurda M; Department of Biometrics, Netherlands Cancer Institute, Amsterdam, the Netherlands.; Grijpink-Ongering LG; Department of Biometrics, Netherlands Cancer Institute, Amsterdam, the Netherlands.; Heeres BC; Department of Radiology, Netherlands Cancer Institute, Amsterdam, the Netherlands.; van de Wiel BA; Department of Pathology, Netherlands Cancer Institute, Amsterdam, the Netherlands.; Flohil C; Department of Pathology, Netherlands Cancer Institute, Amsterdam, the Netherlands.; Sari A; Department of Biometrics, Netherlands Cancer Institute, Amsterdam, the Netherlands.; Heijmink SWTPJ; Department of Radiology, Netherlands Cancer Institute, Amsterdam, the Netherlands.; van den Broek D; Department of Laboratory medicine, Netherlands Cancer Institute, Amsterdam, the Netherlands.; Broeks A; Core Facility Molecular Pathology and Biobanking, Netherlands Cancer Institute, Amsterdam, the Netherlands.; de Groot JWB; Isala Oncology Center, Isala, Zwolle, the Netherlands.; Vollebergh MA; Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, the Netherlands.; Wilgenhof S; Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, the Netherlands.; van Thienen JV; Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, the Netherlands.; Haanen JBAG; Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, the Netherlands; Department of Medical Oncology, Leiden University Medical Center, the Netherlands.; Blank CU; Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, the Netherlands; Department of Medical Oncology, Leiden University Medical Center, the Netherlands; Department of Hematology and Oncology, University of Regensburg, Regensburg, Germany. Electronic address: c.blank@nki.nl.

Publisher: Elsevier Science Ltd Country of Publication: England NLM ID: 9005373 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0852 (Electronic) Linking ISSN: 09598049 NLM ISO Abbreviation: Eur J Cancer Subsets: MEDLINE